Michael Bartlett

Michael Bartlett

Over the past 30 years at the University of Georgia, Michael Bartlett’s group has been involved in the development, validation and implementation of novel bioanalytical methodologies to advance biomedical research. His laboratory works broadly in the areas of drug discovery, development and toxicology, resulting in over 195 peer-reviewed publications in a wide variety of areas. They have studied many aspects involved in the use of LC–MS to evaluate therapeutic oligonucleotides for quality control, bioanalysis, pharmacokinetics and metabolism. They have also adapted many of these approaches to analyze microRNAs as potential disease biomarkers.

Articles by Michael Bartlett

The panelists introduce themselves and outline their practical experience and knowledge of oligonucleotides, setting the stage for an illuminating discussion on current challenges, solutions and innovations in this ten-part panel discussion series organised by LCGC International in collaboration with the Chromatographic Society (ChromSoc).

Latest Updated Articles